Prometheus Biosciences Inc - ESG Rating & Company Profile powered by AI
Alternative companies in the scoring peer group for Prometheus Biosciences Inc are displayed below. This SDG score for Prometheus Biosciences Inc indicates the company's reporting of the United Nations SDGs. This page is a free Environmental, Social and Governance assessment covering Prometheus Biosciences Inc.
Prometheus Biosciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.8; made up of an environmental score of 2.0, social score of 1.6 and governance score of 4.8.
2.8
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1353 | Vera Therapeutics Inc | 2.9 | Medium |
| 1353 | Veracyte Inc | 2.9 | Medium |
| 1393 | Prometheus Biosciences Inc | 2.8 | Medium |
| 1393 | Bioventix PLC | 2.8 | Medium |
| 1393 | Bolt Biotherapeutics Inc | 2.8 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Prometheus Biosciences Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Prometheus Biosciences Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Prometheus Biosciences Inc report the average age of the workforce?
Sign up for free to unlockDoes Prometheus Biosciences Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Prometheus Biosciences Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Prometheus Biosciences Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Prometheus Biosciences Inc offer flexible work?
Sign up for free to unlockDoes Prometheus Biosciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Prometheus Biosciences Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Prometheus Biosciences Inc conduct supply chain audits?
Sign up for free to unlockDoes Prometheus Biosciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Prometheus Biosciences Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Prometheus Biosciences Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Prometheus Biosciences Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Prometheus Biosciences Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Prometheus Biosciences Inc disclose water use targets?
Sign up for free to unlockDoes Prometheus Biosciences Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Prometheus Biosciences Inc have a product recall in the last two years?
Sign up for free to unlockDoes Prometheus Biosciences Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Prometheus Biosciences Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Prometheus Biosciences Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Prometheus Biosciences Inc disclose parental leave metrics?
Sign up for free to unlockDoes Prometheus Biosciences Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Prometheus Biosciences Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Prometheus Biosciences Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Prometheus Biosciences Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Prometheus Biosciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Prometheus Biosciences Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Prometheus Biosciences Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Prometheus Biosciences Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Prometheus Biosciences Inc disclose its waste policy?
Sign up for free to unlockDoes Prometheus Biosciences Inc report according to TCFD requirements?
Sign up for free to unlockDoes Prometheus Biosciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Prometheus Biosciences Inc disclose energy use targets?
Sign up for free to unlockDoes Prometheus Biosciences Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Prometheus Biosciences Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Prometheus Biosciences Inc
These potential risks are based on the size, segment and geographies of the company.
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial for the treatment of ulcerative colitis and Crohn's disease, as well as systemic sclerosis-associated interstitial lung disease. The company also develops PR600, an anti-tumor necrosis factor mAb for IBD; PR300, a G-protein coupled receptor modulator small molecule for IBD; PR1100, an anti-cytokine receptor mAb for IBD and other immune-mediated diseases; PR1800, an anti-chemokine mAb for IBD; and PR2100, an anti-inflammatory cytokine mAb for IBD. It has a diagnostics development and collaboration agreement with Takeda Pharmaceutical Company Limited; co-development and manufacturing agreement with Dr. Falk Pharma GmbH; license agreement with Cedars-Sinai Medical Center; and strategic collaboration with Millennium Pharmaceuticals, Inc. The company was formerly known as Precision IBD, Inc. and changed its name to Prometheus Biosciences, Inc. in October 2019. Prometheus Biosciences, Inc. was incorporated in 2016 and is headquartered in San Diego, California.